PUMA BIOTECHNOLOGY, INC. Finite-Lived Intangible Assets, Accumulated Amortization
PUMA BIOTECHNOLOGY, INC. (PBYI) had Finite-Lived Intangible Assets, Accumulated Amortization of $65.98 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $65.98M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $63.54M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $61.11M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $58.67M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2026-06-30 | $65.98M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $63.54M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $61.11M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $58.67M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $56.24M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $53.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $51.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $48.93M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $46.50M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $44.06M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $41.63M 10-K · filed 2025-02-27 |
| 2023-09-30 | $39.20M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $36.76M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $34.33M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $31.89M 10-K · filed 2024-02-29 |
| 2022-09-30 | $29.89M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $27.88M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $25.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $23.88M 10-K · filed 2023-03-02 |
| 2021-09-30 | $21.87M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $19.87M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $17.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $15.86M 10-K · filed 2022-03-03 |
| 2020-09-30 | $13.86M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.85M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $10.53M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $9.54M 10-K · filed 2021-03-01 |
| 2019-09-30 | $8.55M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.57M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $6.58M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.59M 10-K · filed 2019-03-01 |
| 2018-09-30 | $4.61M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $3.62M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.63M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.65M 10-K · filed 2018-03-09 |
| 2017-09-30 | $621.00K 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |